sequenom massarray panel Search Results


90
Sequenom gene panel sequenom massarray
Gene Panel Sequenom Massarray, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/gene+panel+sequenom+massarray/pm36088508-58-18-20
Average 90 stars, based on 1 article reviews
gene panel sequenom massarray - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sequenom massarray® colon panel
Massarray® Colon Panel, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/massarray++colon+panel/pm29959022-101-76-79
Average 90 stars, based on 1 article reviews
massarray® colon panel - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sequenom massarray oncocarta ® platform
Massarray Oncocarta ® Platform, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/massarray+oncocarta+mutation+profiler+panel/pmc05587199-196-28-27
Average 90 stars, based on 1 article reviews
massarray oncocarta ® platform - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sequenom massarray brca panel
Massarray Brca Panel, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/massarray+brca+panel/pmc08377150-234-24-23
Average 90 stars, based on 1 article reviews
massarray brca panel - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sequenom massarray panel
Massarray Panel, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/massarray+panel/pm23274167-40-8-10
Average 90 stars, based on 1 article reviews
massarray panel - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sequenom massarray melacarta panel
A, B. Geographical distribution and gender of the patients whose melanomas were analyzed for mutations using Sequenom <t>MassARRAY</t> <t>(MelaCarta</t> Panel v1.0). C. Distribution of the anatomical sites of the analyzed metastatic tumour samples. D. Histogram showing the age distribution of the patients.
Massarray Melacarta Panel, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/massarray+melacarta+panel/pmc05173039-89-6-5
Average 90 stars, based on 1 article reviews
massarray melacarta panel - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sequenom multiplex analysis of gene expression system, massarray lungcarta panel
A, B. Geographical distribution and gender of the patients whose melanomas were analyzed for mutations using Sequenom <t>MassARRAY</t> <t>(MelaCarta</t> Panel v1.0). C. Distribution of the anatomical sites of the analyzed metastatic tumour samples. D. Histogram showing the age distribution of the patients.
Multiplex Analysis Of Gene Expression System, Massarray Lungcarta Panel, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/multiplex+analysis+of+gene+expression+system++massarray+lungcarta+panel/pmc10326775-81-20-23
Average 90 stars, based on 1 article reviews
multiplex analysis of gene expression system, massarray lungcarta panel - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sequenom custom panels of ~120 snps on the sequenom massarray system
A, B. Geographical distribution and gender of the patients whose melanomas were analyzed for mutations using Sequenom <t>MassARRAY</t> <t>(MelaCarta</t> Panel v1.0). C. Distribution of the anatomical sites of the analyzed metastatic tumour samples. D. Histogram showing the age distribution of the patients.
Custom Panels Of ~120 Snps On The Sequenom Massarray System, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/custom+panels+of++120+snps+on+the+sequenom+massarray+system/pmc08467714-66-17-16
Average 90 stars, based on 1 article reviews
custom panels of ~120 snps on the sequenom massarray system - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sequenom massarray plex based assay panel
A, B. Geographical distribution and gender of the patients whose melanomas were analyzed for mutations using Sequenom <t>MassARRAY</t> <t>(MelaCarta</t> Panel v1.0). C. Distribution of the anatomical sites of the analyzed metastatic tumour samples. D. Histogram showing the age distribution of the patients.
Massarray Plex Based Assay Panel, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/massarray+plex+based+assay+panel/pm27590425-89-7-6
Average 90 stars, based on 1 article reviews
massarray plex based assay panel - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sequenom snps panel genotyping by maldi-tof mass spectrometry on sequenom massarray platform
A, B. Geographical distribution and gender of the patients whose melanomas were analyzed for mutations using Sequenom <t>MassARRAY</t> <t>(MelaCarta</t> Panel v1.0). C. Distribution of the anatomical sites of the analyzed metastatic tumour samples. D. Histogram showing the age distribution of the patients.
Snps Panel Genotyping By Maldi Tof Mass Spectrometry On Sequenom Massarray Platform, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/snps+panel+genotyping+by+maldi+tof+mass+spectrometry+on+sequenom+massarray+platform/pm37165071-4544-20-19
Average 90 stars, based on 1 article reviews
snps panel genotyping by maldi-tof mass spectrometry on sequenom massarray platform - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sequenom massarray-based targeted leukemia mutation panel
A, B. Geographical distribution and gender of the patients whose melanomas were analyzed for mutations using Sequenom <t>MassARRAY</t> <t>(MelaCarta</t> Panel v1.0). C. Distribution of the anatomical sites of the analyzed metastatic tumour samples. D. Histogram showing the age distribution of the patients.
Massarray Based Targeted Leukemia Mutation Panel, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/massarray+based+targeted+leukemia+mutation+panel/10__1016_slash_s1525___1578_ascii40_10_ascii41_60136___5-736-9-9
Average 90 stars, based on 1 article reviews
massarray-based targeted leukemia mutation panel - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sequenom sequenom® massarray-based multiplex mutation detection panel
A, B. Geographical distribution and gender of the patients whose melanomas were analyzed for mutations using Sequenom <t>MassARRAY</t> <t>(MelaCarta</t> Panel v1.0). C. Distribution of the anatomical sites of the analyzed metastatic tumour samples. D. Histogram showing the age distribution of the patients.
Sequenom® Massarray Based Multiplex Mutation Detection Panel, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/sequenom++massarray+based+multiplex+mutation+detection+panel/10__1016_slash_s1525___1578_ascii40_11_ascii41_00254___6-4179-5-4
Average 90 stars, based on 1 article reviews
sequenom® massarray-based multiplex mutation detection panel - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


A, B. Geographical distribution and gender of the patients whose melanomas were analyzed for mutations using Sequenom MassARRAY (MelaCarta Panel v1.0). C. Distribution of the anatomical sites of the analyzed metastatic tumour samples. D. Histogram showing the age distribution of the patients.

Journal: Oncotarget

Article Title: NRAS and EPHB6 mutation rates differ in metastatic melanomas of patients in the North Island versus South Island of New Zealand

doi: 10.18632/oncotarget.9351

Figure Lengend Snippet: A, B. Geographical distribution and gender of the patients whose melanomas were analyzed for mutations using Sequenom MassARRAY (MelaCarta Panel v1.0). C. Distribution of the anatomical sites of the analyzed metastatic tumour samples. D. Histogram showing the age distribution of the patients.

Article Snippet: Samples were analyzed using the Sequenom MassARRAY MelaCarta panel of recurrently mutated melanoma genes, and also by direct Sanger sequencing of BRAF exon 15, which served to identify the full extent of BRAF exon 15 mutations, and to provide validation of the BRAF MelaCarta mutation data.

Techniques:

Predicted amino acid mutations in NZ melanomas identified in BRAF outside codon 600 detected using Sanger sequencing and/or Sequenom  MelaCarta

Journal: Oncotarget

Article Title: NRAS and EPHB6 mutation rates differ in metastatic melanomas of patients in the North Island versus South Island of New Zealand

doi: 10.18632/oncotarget.9351

Figure Lengend Snippet: Predicted amino acid mutations in NZ melanomas identified in BRAF outside codon 600 detected using Sanger sequencing and/or Sequenom MelaCarta

Article Snippet: Samples were analyzed using the Sequenom MassARRAY MelaCarta panel of recurrently mutated melanoma genes, and also by direct Sanger sequencing of BRAF exon 15, which served to identify the full extent of BRAF exon 15 mutations, and to provide validation of the BRAF MelaCarta mutation data.

Techniques: Sequencing, Mutagenesis

A. Oncoprint of mutations identified with the Sequenom MassARRAY (MelaCarta Panel) in 466 patients. The oncoprint was generated using cBioportal tools. B. Comparison of BRAF and NRAS mutations in the NZ population with the TCGA patient cohort.

Journal: Oncotarget

Article Title: NRAS and EPHB6 mutation rates differ in metastatic melanomas of patients in the North Island versus South Island of New Zealand

doi: 10.18632/oncotarget.9351

Figure Lengend Snippet: A. Oncoprint of mutations identified with the Sequenom MassARRAY (MelaCarta Panel) in 466 patients. The oncoprint was generated using cBioportal tools. B. Comparison of BRAF and NRAS mutations in the NZ population with the TCGA patient cohort.

Article Snippet: Samples were analyzed using the Sequenom MassARRAY MelaCarta panel of recurrently mutated melanoma genes, and also by direct Sanger sequencing of BRAF exon 15, which served to identify the full extent of BRAF exon 15 mutations, and to provide validation of the BRAF MelaCarta mutation data.

Techniques: Generated

Additional mutations identified by Sequenom  Melacarta  analysis in NZ melanomas

Journal: Oncotarget

Article Title: NRAS and EPHB6 mutation rates differ in metastatic melanomas of patients in the North Island versus South Island of New Zealand

doi: 10.18632/oncotarget.9351

Figure Lengend Snippet: Additional mutations identified by Sequenom Melacarta analysis in NZ melanomas

Article Snippet: Samples were analyzed using the Sequenom MassARRAY MelaCarta panel of recurrently mutated melanoma genes, and also by direct Sanger sequencing of BRAF exon 15, which served to identify the full extent of BRAF exon 15 mutations, and to provide validation of the BRAF MelaCarta mutation data.

Techniques: Mutagenesis